DICE Therapeutics Inc.

NASDAQ: DICE · Real-Time Price · USD
47.55
0.03 (0.06%)
At close: Aug 08, 2023, 10:00 PM

DICE Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-83.89M -48.96M
Depreciation & Amortization
2.42M 661K
Stock-Based Compensation
12.82M 5.58M
Other Working Capital
-191K 2.42M
Other Non-Cash Items
1.67M 107K
Deferred Income Tax
n/a 1.67M
Change in Working Capital
2.64M 1.65M
Operating Cash Flow
-64.32M -39.29M
Capital Expenditures
-2.24M -718K
Cash Acquisitions
n/a n/a
Purchase of Investments
-139.25M -218.47M
Sales Maturities Of Investments
228.98M 14.56M
Other Investing Acitivies
n/a n/a
Investing Cash Flow
87.49M -204.62M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
322.25M 300.25M
Financial Cash Flow
322.25M 300.25M
Net Cash Flow
345.42M 56.34M
Free Cash Flow
-66.56M -40.01M